课题基金 / 基金详情

The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis

The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis
TIMP 在细胞生长、肿瘤进展和转移中的作用
批准号:
10703000
负责人:
William Stetler-Stevenson
金额:
$53.85万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

William Stetler-Stevenson的其他基金

相似基金

相关文献

中文摘要
翻译
主要活动/具体目标。我们正在进行的研究工作的主要目标 是深入了解MMP独立活动的机制, TIMP家族成员,特别是TIMP-2。我们已经确定了以下具体 目的:1)研究TIMPs在改变生长中的作用, 2)TIMP对肿瘤细胞体外侵袭能力的影响; 体内转移性肿瘤生长; 3)研究TIMPs对肿瘤细胞募集的影响, 免疫调节细胞(骨髓源性抑制细胞(MDSC))对原发性肿瘤的作用, 4)更好地理解细胞间 TIMP。在先前的实验中,我们观察到TIMP-2在肿瘤细胞中的强制表达 抑制原发性肿瘤生长。肿瘤生长的抑制伴随着 肿瘤微血管密度计数(CD 31+或CD 34+)统计学显著降低, 抗血管生成作用的测量,以及增加的肿瘤细胞凋亡(也可能是 由于抑制血管生成)。有点出乎意料的是,我们还观察到, 在TIMP-2表达肿瘤中,粘着斑激酶(FAK)显著降低, 在表达TIMP-2和Ala+TIMP-2的肿瘤细胞中,这两种肿瘤细胞都具有磷酸化(Y397)。我们的观察 FAK和/或AKT(蛋白激酶B,PKB)磷酸化在TIMP-2中减少, Ala+TIMP-2在肿瘤组织中的意义在于:1)FAK是AKT信号传导的上游, TIMP-2和Ala+TIMP-2表达减少 体外肿瘤细胞迁移。我们以前报道过, 在内皮细胞中,它参与控制eNOS活性。在我的实验室里, 在小鼠肿瘤模型中检测外源性TIMP-2的作用。我们正在研究 对肿瘤生长和转移的影响,目的是更好地了解 这些最新的发现表明TIMP-2可能与细胞凋亡有关。 对肿瘤和宿主细胞都有多种作用,这些作用联合收割机产生一种有效的 可以用于临床的抗肿瘤活性。
英文摘要
Major Activities/Specific Objectives. The principal goal of our ongoing research effort is to develop an in depth mechanistic understanding of the MMP-independent activities of members of the TIMP family, in particular TIMP-2. We have identified the following specific objectives to obtain our goals: 1) examine the role of TIMPs in altering the growth and invasive potential of cancer cells in vitro; 2) study to effects of TIMPs on primary and metastatic tumor growth in vivo; 3) study the influence of TIMPs on recruitment of immune-modulatory cells (myeloid-derived suppressor cells (MDSC)) to the primary tumor and metastatic niche4) develop a better understanding of the uptake and role of intercellular TIMP. In prior experiments with forced expression of TIMP-2 in tumor cells we have observed suppression of primary tumor growth. The suppression of tumor growth was accompanied by a statistically significant decrease in tumor microvascular density count (CD 31+ or CD34+), a measure of antiangiogenic effects, as well as by increased tumor cell apoptosis (also possibly due to inhibition of angiogenesis). Somewhat unexpectedly, we also observed a decrease in focal adhesion kinase (FAK) in TIMP-2 expressing tumors and a significant decrease in FAK phosphorylation (Y397) in both TIMP-2 and Ala+TIMP-2 expressing tumor cells. Our observation that both FAK and/or AKT (Protein Kinase B, PKB) phosphorylation is reduced in TIMP-2 and Ala+TIMP-2 tumor tissues is significant in that: 1) FAK is upstream of AKT signaling, and both are involved in regulation of cell migration; 2) TIMP-2 and Ala+TIMP-2 expression reduced tumor cell migration in vitro. We previously reported decreased FAK phosphorylation in endothelial cells where it is involved in control of eNOS activity. A major focus in my lab has been to examine the effects of exogenous TIMP-2 in murine tumor models. We are studying the effects on tumor growth and metastasis with the aim of developing a better understanding of the mechanisms that may affect these processes.These recent findings suggest that TIMP-2 has a variety of effects on both tumor and host cells that combine to produce a potent anti-tumor activity that could be exploited clinically.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of TIMP-2 derivatives or strategies as biologic therapies for cancer
  • 批准号:
    10486788
  • 项目类别:
  • 资助金额:
    $101.15万
  • 财政年份:
    --
  • 负责人:
    William Stetler-Stevenson
  • 依托单位:
Preclinical development of AlaTIMP-2 as an cancer therapeutic
  • 批准号:
    7966212
  • 项目类别:
  • 资助金额:
    $101.24万
  • 财政年份:
    --
  • 负责人:
    William Stetler-Stevenson
  • 依托单位:
Preclinical development of Ala+TIMP-2 as an cancer therapeutic
  • 批准号:
    8763396
  • 项目类别:
  • 资助金额:
    $94.35万
  • 财政年份:
    --
  • 负责人:
    William Stetler-Stevenson
  • 依托单位:
Development of TIMP-2 derivatives or strategies as biologic therapies for cancer
  • 批准号:
    10014569
  • 项目类别:
  • 资助金额:
    $81.72万
  • 财政年份:
    --
  • 负责人:
    William Stetler-Stevenson
  • 依托单位:
海外基金